【#Theranos: Medical device for analyte monitoring and drug delivery】
This one is controversial – Theranos practically went from one of Silicon Valley’s hottest names to a spectacular failure virtually overnight. After being accused of years of fraud, Theranos officially shut down in September 2018. But in March of this year — and just a few months after its death — the company was granted its first blood-testing patent of 2019. Since then, Theranos has been granted 4 additional patents. his application filed in August 2005 was her first. Based on a vision of rapid medical diagnosis and treatment, the method is a wearable patch to help administer drugs, monitor patients’ variables in the blood, while adjusting the dosage as needed. Many other patent applications – Holmes is listed as a co-inventor on over 100 – have followed, including one in 2007, Real-time detection of influenza virus. Considering that the World Health Organization estimates an annual influenza death toll worldwide of between 250,000 to 500,000, that could be a lucrative patent. By 2014, Theranos had raised over $400 million and was valued in the neighborhood of $10 billion.
+603-5891 4846
+603-5879 9908
Comments are closed.